SFCM
BEAM icon

Seven Fleet Capital Management’s Beam Therapeutics BEAM Stock Holding History

Seven Fleet Capital Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$210K Sell
8,804
-733
-8% -$20.3K 0.07% 104
2025
Q4 		$264K Buy
+9,537
New +$243K 0.18% 60

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Seven Fleet Capital Management's BEAM Position: Q1 2026 in Review

Seven Fleet Capital Management reduced its Beam Therapeutics (BEAM) stake by 7.7% in Q1 2026, selling an estimated $20.3K and leaving 8,804 shares worth $210K. The position accounts for 0.07% of the portfolio, ranked #104.

Seven Fleet Capital Management first reported a position in BEAM in Q4 2025 and has held it in 2 quarters since. The position peaked at $264K in Q4 2025. 252 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Seven Fleet Capital Management held 8,804 shares of Beam Therapeutics worth $210K as of Q1 2026.
  • Seven Fleet Capital Management sold 733 Beam Therapeutics shares in Q1 2026, an estimated $20.3K.
  • Beam Therapeutics made up 0.07% of Seven Fleet Capital Management's portfolio in Q1 2026, its #104 holding.
  • Seven Fleet Capital Management first reported a position in Beam Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Seven Fleet Capital Management's Beam Therapeutics position peaked at $264K in Q4 2025.
  • 252 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Seven Fleet Capital Management's 13F filing for Q1 2026, filed 15 May 2026.